Did you know?

ChinaBio^® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

Free Report

State of China Life Science 2022

Free Content

Week in Review

In My Opinion

Free Articles

Subscriber Content

Chunli to Market Novel Orthopedic Implants from Germany's Syntellix in China

publication date: Sep 3, 2019

Beijing Chunlizhengda Medical Instruments partnered with Germany's Syntellix to import Syntellix's innovative magnesium alloy orthopedic implants into China. Chunli will make milestone payments to Syntellix for revenues that are greater than $110 million over five years. Syntellix's magnesium alloy orthopedic products are bioabsorbable. Besides marketing and distribution, the agreement includes China R&D, academic projects and training activities. Both companies are confident that China sales will top the $110 million minimum. More details....

Stock Symbol: (HK: 1858)

Share this with colleagues:

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Click here to join.